Feb 14, 2020 / 04:30PM GMT
Operator
Good morning. My name is Sylvie, and I will be your conference operator today. At this time, I would like to welcome everyone to InMed's Second Quarter Fiscal Year 2020 Financial Results and Business Update Conference Call for the period ending December 31, 2019. (Operator Instructions) Mr. Payne, you may go ahead and begin.
Brendan Payne - InMed Pharmaceuticals Inc. - Director of IR
Thank you, Sylvie, and good day, ladies and gentlemen. My name is Brendan Payne, InMed's Director of Investor Relations. Welcome to InMed's Second Quarter Fiscal Year 2020 Financial Results and Business Update Conference Call.
Before we begin, we would like to go over our disclosure statements, followed by a review of the progress on our biosynthesis and therapeutic development programs, which will be led by our President and CEO, Eric Adams. Mr. Bruce Colwill, our CFO, will then review the financial results of operations. Following that, we will be available for a question-and-answer session. Also joining us today to address your questions will be Eric Hsu, Senior Vice
Q2 2020 InMed Pharmaceuticals Inc Earnings Call Transcript
Mar 06, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers